Can I Take 5-HTP with Rezdiffra (Resmetirom)?
A physician-reviewed guide to the 5-HTP and Rezdiffra (resmetirom) interaction: mechanism, serotonin syndrome risk, pharmacokinetics, monitoring, and safe-use guidance for patients with MASH.
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 30 of 30 clinical reviews.
A physician-reviewed guide to the 5-HTP and Rezdiffra (resmetirom) interaction: mechanism, serotonin syndrome risk, pharmacokinetics, monitoring, and safe-use guidance for patients with MASH.
A clinical review of the pharmacodynamic and pharmacokinetic interactions between alpha-lipoic acid and resmetirom (Rezdiffra), covering hypoglycemia risk, thyroid hormone effects, monitoring, and dosing guidance for patients with MASH.
A clinical review of the ashwagandha-resmetirom interaction, covering pharmacokinetic and pharmacodynamic concerns, thyroid effects, cortisol modulation, and practical monitoring guidance for patients on Rezdiffra.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between berberine and resmetirom (Rezdiffra) for patients managing MASH, including monitoring guidance and dose considerations.
A clinician-reviewed guide to the caffeine-resmetirom interaction: CYP1A2 pharmacokinetics, hemodynamic effects on a fibrotic liver, dose-timing strategies, and monitoring benchmarks for patients on Rezdiffra.
A physician-reviewed guide to calcium and resmetirom (Rezdiffra) interactions, covering pharmacokinetics, dose-separation windows, monitoring parameters, and safety evidence for MASH patients.
Evidence-based guide to combining CoQ10 supplements with Rezdiffra (resmetirom) for MASH. Covers interaction risk, pharmacokinetics, dose-separation strategy, and monitoring.
A physician-reviewed guide to the creatine and Rezdiffra (resmetirom) interaction, covering mechanism, creatinine monitoring, renal safety, and practical dosing guidance for patients with MASH.
A physician-reviewed guide to combining folate with Rezdiffra (resmetirom) for MASH, covering pharmacokinetics, MTHFR status, dosing, monitoring, and safety.
A clinical review of the ginseng-resmetirom interaction: pharmacokinetic and pharmacodynamic risks, glucose monitoring, anticoagulant concerns, and what to do if you are already taking both.
A physician-reviewed guide to combining glutathione supplements with Rezdiffra (resmetirom) for MASH: interaction mechanisms, safety evidence, dosing timing, and monitoring recommendations.
Evidence-based guide on combining glycine supplements with Rezdiffra (resmetirom) for MASH. Covers pharmacokinetic interactions, dose-separation, monitoring, and safety data.
A physician-reviewed guide to the hepatotoxicity and pharmacokinetic risks of combining green tea extract or EGCG with resmetirom (Rezdiffra) for MASH, including dosing guidance, monitoring, and when to stop.
A physician-reviewed guide to the L-theanine and resmetirom interaction: mechanism, safety evidence, monitoring, and practical dosing guidance for MASH patients.
A clinician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction between lion's mane mushroom and resmetirom (Rezdiffra), with dosing guidance, monitoring parameters, and safety recommendations for MASH patients.
A clinician-reviewed guide to magnesium and resmetirom (Rezdiffra) co-administration: interaction mechanism, safety evidence, dosing strategy, and monitoring recommendations for MASH patients.
A physician-reviewed guide on the melatonin, resmetirom interaction: mechanisms, safety evidence, dosing timing, monitoring, and what to tell your prescriber.
Evidence-based guide on combining NAC supplements with Rezdiffra (resmetirom) for MASH. Covers drug-supplement interactions, pharmacokinetics, dosing windows, and monitoring recommendations.
Evidence-based guide on combining omega-3 fish oil (EPA/DHA) with Rezdiffra (resmetirom) for MASH. Covers drug-supplement interactions, monitoring, dose separation, and clinical trial data.
A clinician-reviewed guide to the pharmacokinetic and pharmacodynamic interaction between quercetin and resmetirom (Rezdiffra), with dosing guidance, monitoring parameters, and safety considerations for MASH patients.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between reishi mushroom and resmetirom (Rezdiffra), with dosing guidance, monitoring protocols, and safety recommendations for MASH patients.
Resveratrol may inhibit CYP3A4 and alter resmetirom exposure. Learn about the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to tell your prescriber if you already take both.
A clinical review of the potential interactions between rhodiola rosea supplements and resmetirom (Rezdiffra) for MASH, covering pharmacokinetics, serotonergic effects, and monitoring guidance.
A clinical review of the saw palmetto and resmetirom interaction: pharmacokinetics, pharmacodynamics, monitoring recommendations, and what to tell your prescriber before combining both.
St. John's Wort is a potent CYP3A4 inducer that can significantly lower resmetirom blood levels, potentially making Rezdiffra less effective for MASH. Learn the mechanism, the clinical risk, and what your prescriber needs to know.
Evidence-based guide to taking turmeric or curcumin supplements alongside Rezdiffra (resmetirom) for MASH, including interaction risks, dose-separation strategies, and monitoring recommendations.
A clinical review of vitamin B12 safety, interactions, and monitoring when combined with resmetirom (Rezdiffra) for MASH. Written by the HealthRX medical team.
A clinician-reviewed guide to the vitamin B6 and resmetirom (Rezdiffra) interaction: pharmacokinetics, neuropathy risk, safe dosing, and monitoring recommendations for MASH patients.
A physician-reviewed guide to taking vitamin D alongside Rezdiffra (resmetirom) for MASH: interaction mechanisms, safety evidence, monitoring tips, and dosing guidance.
A physician-reviewed guide to zinc and Rezdiffra (resmetirom) interactions, covering pharmacokinetics, thyroid hormone effects, copper balance, monitoring, and practical dosing guidance for MASH patients.